Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Credit

<ul><li>Agilent ended the year 2021 on a highly positive note with a top-line of $6.32 billion and revenues growing by as much as $1 billion (around 15%).</li><li>The company provided analytical informatics and instruments to a wide customer range along with consumables and related services that ensure strong revenue stickiness.</li><li>In this report, we have carried out a fundamental analysis of the historical financial statements of the company.</li></ul>

Agilent ended the year 2021 on a highly positive note with a top-line of $6.32 billion and revenues growing by as much as $1 billion (around 15%).The company provided analytical informatics and instruments to a wide customer range along with consumables and related services that ensure strong revenue stickiness.In this report, we have carried out a fundamental analysis of the historical financial statements of the company.

Agilent Technologies: Detailed Credit Analysis & Financial Strength Evaluation Report

Equity Capital Markets

Agilent Technologies / Equity Capital Markets

<ul><li>Agilent had a particularly strong 2021 with revenues growing by as much as $1 billion (nearly 15%).</li><li>Agilent supplied analytical informatics and instruments to a wide customer range along with consumables and related services that ensure strong revenue stickiness.</li><li>Agilent is well-positioned to continue its momentum in 2022 and we give the stock a ‘Hold’ rating with a revised target price.</li></ul>

Agilent had a particularly strong 2021 with revenues growing by as much as $1 billion (nearly 15%).Agilent supplied analytical informatics and instruments to a wide customer range along with consumables and related services that ensure strong revenue stickiness.Agilent is well-positioned to continue its momentum in 2022 and we give the stock a ‘Hold’ rating with a revised target price.

Agilent Technologies Inc.: Financial & Price Forecasts

<ul><li>Agilent had another strong quarter to close out an exceptional 2021.</li><li>At $6.32 billion for fiscal 2021, its revenues are over $1 billion higher than last year.</li><li>The company has been supplying analytical instruments and informatics to a vast customer base followed by providing related services and consumables ensuring a strong revenue stickiness.</li></ul>

Agilent had another strong quarter to close out an exceptional 2021.At $6.32 billion for fiscal 2021, its revenues are over $1 billion higher than last year.The company has been supplying analytical instruments and informatics to a vast customer base followed by providing related services and consumables ensuring a strong revenue stickiness.

Agilent Technologies Inc. - Investment Thesis

Asset Allocation & Fund Positioning, Copley Fund Research

Steven Holden

Asset Allocation & Fund Positioning

Copley Fund Research

Copley Fund Research provide research and data on asset allocation among Global and Emerging Market equity funds.  The analysis details absolute and relative positioning across countries, sectors and industries together with highly granular data on single stock and single fund allocations.  The data is updated monthly with time series going back to January 2011.

Global Research - Analysis of 165 prominent Global equity funds, combined AUM $335bn
GEM Research - Analysis of 127 prominent global EM equity funds, combined AUM $250bn

Asset Allocation - Global and GEM Equity

Cross Asset Strategy

Over 50% of allocations are in the US with the bulk of the remainder split between Japan, China &amp; HK and the major European nations.  The EMEA overweight is comprised mainly of the UK, Netherlands, France and Germany, with active managers running underweights in the US, China &amp; HK, Australia and Japan.UK allocations hover around their lowest levels in history, though managers remain stubbornly overweight compared to the MSCI AC World index.  A total of 62% of managers are overweight the UK at an average +1.88% above benchmark.  Global Value investors are approaching their largest ever overweight in UK stocks of 3.64% above benchmark.Another month, another slump in Japan exposure.  Average weights in Japan stand at an all-time low of 5.06% with 85.5% of funds exposed (another low). <a href="https://www.smartkarma.com/entities/sony-corp" target="_blank" data-smartkarma-citation="entities:563:1" rel="noopener">Sony Corp (6758 JP)</a> and <a href="https://www.smartkarma.com/entities/kddi-corp" target="_blank" data-smartkarma-citation="entities:639:1" rel="noopener">KDDI Corp (9433 JP)</a> are the most widely held stocks, with 23% and 21% of funds holding a position.Tech exposure is at record highs, though this is matched by a record underweight of -0.47%.  Indeed, the percentage of funds who are overweight technology has fallen to below 50% for the first time since the end of 2018, a sign that Global managers are tilting their portfolios away from Tech.German Industrials allocations have hit a 4-year high as more Global investors add exposure to the sector. <a href="https://www.smartkarma.com/entities/deutsche-post-ag" target="_blank" data-smartkarma-citation="entities:21608:1" rel="noopener">Deutsche Post AG (DPW GR)</a> and <a href="https://www.smartkarma.com/entities/siemens-ag" target="_blank" data-smartkarma-citation="entities:21713:1" rel="noopener">Siemens AG (SIE GR)</a> were the key stocks behind the move, with 4.2% and 2.4% of funds adding exposure over the last 6-months.Alibaba has seen closures by some of the larger holders in our analysis, led by American Funds Capital World Fund (-$1.1bn) and New Economy Fund (-$451m).  Though closures have dominated, selected funds have opened exposure during this period of volatility, including Invesco's Global Focus Fund and Liontrust's Global Income Fund.

Over 50% of allocations are in the US with the bulk of the remainder split between Japan, China &amp; HK and the major European nations.  The EMEA overweight is comprised mainly of the UK, Netherlands, France and Germany, with active managers running underweights in the US, China &amp; HK, Australia and Japan.UK allocations hover around their lowest levels in history, though managers remain stubbornly overweight compared to the MSCI AC World index.  A total of 62% of managers are overweight the UK at an average +1.88% above benchmark.  Global Value investors are approaching their largest ever overweight in UK stocks of 3.64% above benchmark.Another month, another slump in Japan exposure.  Average weights in Japan stand at an all-time low of 5.06% with 85.5% of funds exposed (another low). Sony Corp (6758 JP) and KDDI Corp (9433 JP) are the most widely held stocks, with 23% and 21% of funds holding a position.Tech exposure is at record highs, though this is matched by a record underweight of -0.47%.  Indeed, the percentage of funds who are overweight technology has fallen to below 50% for the first time since the end of 2018, a sign that Global managers are tilting their portfolios away from Tech.German Industrials allocations have hit a 4-year high as more Global investors add exposure to the sector. Deutsche Post AG (DPW GR) and Siemens AG (SIE GR) were the key stocks behind the move, with 4.2% and 2.4% of funds adding exposure over the last 6-months.Alibaba has seen closures by some of the larger holders in our analysis, led by American Funds Capital World Fund (-$1.1bn) and New Economy Fund (-$451m).  Though closures have dominated, selected funds have opened exposure during this period of volatility, including Invesco's Global Focus Fund and Liontrust's Global Income Fund.

Global Fund Positioning Update:  Japan Lows, US Highs, UK Value Rotation, Tencent & Alibaba Exit

<ul><li>Agilent Technologies delivered another outstanding quarter with a staggering 26% growth in the top-line.</li><li>Cell Analysis, Liquid Chromatography and Mass Spectrometry platforms continued to be a major growth driver and with the Life Sciences and Applied Markets Group alone delivering a 43% growth.</li><li>It is worth noting that Agilent has significantly increased their R&D spends by 22.8% in the quarter so we can expect some major product announcements in the coming quarters.</li></ul>

Agilent Technologies delivered another outstanding quarter with a staggering 26% growth in the top-line.Cell Analysis, Liquid Chromatography and Mass Spectrometry platforms continued to be a major growth driver and with the Life Sciences and Applied Markets Group alone delivering a 43% growth.It is worth noting that Agilent has significantly increased their R&D spends by 22.8% in the quarter so we can expect some major product announcements in the coming quarters.

United States

Agilent Technologies, Inc. provides core bio-analytical and electronic measurement solutions to the communications, electronics, life sciences, and chemical analysis industries. The Company offers electronic and bio-analytical measurement, semiconductor, and board testing.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Agilent Technologies (A US)

Agilent Technologies: Detailed Credit Analysis & Financial Strength Evaluation Report

Agilent ended the year 2021 on a highly positive note with a top-line of $6.32 billion and revenues growing by as much as $1 billion (around...

Baptista Research

Agilent Technologies Inc.: Financial & Price Forecasts

Agilent had a particularly strong 2021 with revenues growing by as much as $1 billion (nearly 15%). Agilent supplied analytical informatics and...

Baptista Research

Agilent Technologies Inc. - Investment Thesis

Agilent had another strong quarter to close out an exceptional 2021. At $6.32 billion for fiscal 2021, its revenues are over $1 billion higher...

Baptista Research

Global Fund Positioning Update: Japan Lows, US Highs, UK Value Rotation, Tencent & Alibaba Exit

A detailed look at investor positioning among 380 active Global strategies, covering the major themes in country, sector and stock exposure.

Steven Holden

Agilent Technologies Inc. - Investment Thesis

Agilent Technologies delivered another outstanding quarter with a staggering 26% growth in the top-line. Cell Analysis, Liquid Chromatography and...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)